Skip to main content
. Author manuscript; available in PMC: 2009 May 11.
Published in final edited form as: Arthritis Rheum. 2008 Dec;58(12):3924–3931. doi: 10.1002/art.24137

Table 2.

Differentiation of SJIA versus bacterial infections and NOMID with S100A12 at various cut-offs.

Parameter Area under the curve Cut-off Sensitivity Specificity Positive Likelihood ratio
SJIA vs infections 0.881 ± 0.078 800 ng/ml 85% 89% 7.7
1400 ng/ml 66% 94% 11.0
2750 ng/ml 55% 97% 18.3
SJIA vs NOMID 0.866 ± 0.084 800 ng/ml 84% 72% 3.0
1400 ng/ml 66% 89% 6.0
2750 ng/ml 54% 94% 9.0
SJIA vs MWS 0.972 ± 0.031 1000 ng/ml 78% 100% n.a.
SJIA vs ALL 0.981 ± 0.024 1000 ng/ml 78% 100% n.a.
SJIA vs AML 1.000 ± 0.0 150 ng/ml 97% 100% n.a.
SJIA vs healthy controls 0.994 ± 0.012 150 ng/ml 98% 100% n.a.

vs=versus; n.a.=not applicable, LR+ is going to infinity in these cases